Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2019-02-28FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) by Bayer HealthCare LLC, indicating a labeling change or addition.…
-
FDA approval · 2019-02-28FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
The FDA approved a supplemental application for Claritin RediTabs containing loratadine, introducing a new dosage form under Bayer Healthcar…
-
FDA approval · 2019-02-21FDA Approved: PREDNISONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prednisone from Mylan Pharmaceuticals, indicating approval of an existing generic product's …
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
A completed clinical trial from Thailand reports real-world management and therapeutic outcomes for patients with allergic rhinitis, nonalle…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Evaluation of an Integrated Care Project
Completed clinical trial update from Charite University on an integrated care project addressing asthma, allergic rhinitis, atopic eczema, m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2019-02-06FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC. The action involves updates to the prod…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR) [Phase 4]
Phase 4 trial comparing two doses of Fluticasone Furoate Nasal Spray in Chinese pediatric subjects with allergic rhinitis; study completed w…
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Molekule for Allergic Rhinitis/Asthma [NA]
A Molekule-sponsored clinical trial for asthma and allergic rhinitis (and allergic conjunctivitis) has been terminated.
-
FDA approval · 2019-01-31FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved an Original Application for Phenylephrine Hydrochloride from Sandoz Inc, enabling the marketing of this generic product.
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest [NA]
This clinical trial update evaluates whether a tape-based skin prick test provides diagnostically equivalent results to the conventional Ski…
-
FDA approval · 2019-01-28FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for azelastine hydrochloride from Apotex Corp.
-
FDA approval · 2019-01-25FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for ADVIL ALLERGY AND CONGESTION RELIEF, a combination product containing chlorpheniramine maleate, …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal [Phase 3]
Phase 3 trial comparing a nasal spray containing naphazoline hydrochloride, pheniramine maleate, and panthenol versus naphazoline hydrochlor…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice
A completed clinical trial evaluated the tolerability and safety of Allergovac Poliplus in polysensitized patients with allergic rhinitis or…
-
CLINICAL_TRIALS withdrawal · 2019-01-23Clinical Trial Update: Diesel Exhaust Particles and Leukotriene Production
A clinical trial investigating the effects of diesel exhaust particles on leukotriene production in allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS research · 2019-01-23Clinical Trial Update: Healthcare Decisions on Dietary and Environmental Allergen Exposure
A clinical trial update from a sponsor focusing on decisions around exposure to dietary (food) and environmental allergens; the study status…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) [Phase 4]
Phase 4 trial update for ATAREAL evaluating antihistamine treatment in allergic perennial rhinitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Depigoid Birch 5000 Longterm Study in Adults and Adolescents [Phase 3]
Phase 3 long-term study update for Depigoid Birch 5000 in adults and adolescents with birch pollen allergy and related rhinitis/sensitoconju…
-
FDA label_change · 2019-01-11FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) from Chattem, Inc., resulting in changes to the produ…
-
FDA approval · 2019-01-07FDA Approved: FLUTICASONE PROPIONATE HFA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate HFA filed by Prasco Laboratories. The approval updates the product under …
-
FDA approval · 2019-01-03FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Claritin Chewable Grape and Bubblegum (loratadine) under the Claritin label, expanding the pr…
-
FDA approval · 2018-12-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application to the Singulair (montelukast) NDA submitted by Organon LLC.
-
FDA approval · 2018-12-21FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) held by Bayer HealthCare LLC.
-
FDA label_change · 2018-12-21FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Liqui-Gels (loratadine) by Bayer HealthCare LLC, indicating a labeling-related update.
-
FDA approval · 2018-12-21FDA Approved: LORATADINE — Original Application (Bionpharma Inc.)
The FDA approved Bionpharma Inc.'s original ANDA for loratadine, authorizing a generic loratadine product to be marketed in the United State…